天然由来の抗菌補助剤によるプラスミド媒介性細菌耐性の逆転
Linyu Wu1, Xinyuan Zhang1, Peter Oelschlaeger2
1Department of Forestry Chemical Engineering, Shaanxi Key Laboratory of Economic Plant Resources Development and Utilization, Forestry College, Northwest A&F University, Yangling, Shaanxi 712100, P. R. China.
Abstract:
The clinical efficacy of β-lactams, polymyxins, and tetracyclines is especially increasingly compromised by plasmid-mediated resistance mechanisms. These include but are not limited to expression of β-lactamases (BLs), MCRs (encoded by the mcrs colistin resistance gene), and TetX (encoded by the tet(X3)/tet(X4) tetracycline resistance gene), which have constituted a significant menace to public health and food safety, triggering urgent concern worldwide. Combating this crisis requires innovative approaches, among which the development of antimicrobial adjuvants that synergize with existing antibiotics holds particular promise for reclaiming lost therapeutic efficacy. This review systematically summarizes the plasmid-mediated resistance mechanisms that inactivate β-lactams, polymyxins, and tetracyclines. Furthermore, we provide a detailed overview of all identified natural product chemotypes capable of inhibiting SBLs, MBLs, MCRs, and Tet(X3)/Tet(X4) enzymes or functioning as antimicrobial adjuvants along with their mechanisms of action. These findings establish fundamental principles to guide the development of broad-spectrum antimicrobial adjuvants aimed at counteracting plasmid-mediated bacterial resistance.
関連する概念動画
Bacterial Transformation
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
Antimicrobial Effectiveness
Plasmids
What is Natural Selection?
Nature and Nurture
Bacterial Signaling


